Evidence map›Paper›PMID 38560372›Full record

ArticleHeart rhythm O22024

Trends in the 30-year span of noninfectious cardiovascular implantable electronic device complications in Olmsted County.

Gurukripa N Kowlgi, Vaibhav Vaidya, Ming-Yan Dai, Pragyat Futela, Rahul Mishra, David O Hodge, Abhishek J Deshmukh, Siva K Mulpuru, Paul A Friedman, Yong-Mei Cha

Open access · goldAbstract read
In one paragraph

Article in Heart rhythm O2, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Gurukripa N KowlgiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Vaibhav VaidyaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Ming-Yan DaiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Pragyat FutelaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Rahul MishraDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
David O HodgeDepartment of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida.
Abhishek J DeshmukhDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Siva K MulpuruDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Paul A FriedmanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Yong-Mei ChaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
NIA NIH HHS R01 AG034676NIA NIH HHS R33 AG058738
6 · The paper itself

Abstract

Background: Cardiac implantable electronic devices (CIEDs), such as permanent pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices, alleviate morbidity and mortality in various diseases. There is a paucity of real-world data on CIED complications and trends. Objectives: We sought to describe trends in noninfectious CIED complications over the past 3 decades in Olmsted County. Methods: The Rochester Epidemiology Project is a medical records linkage system comprising records of over 500,000 residents of Olmsted County from 1966 to present. CIED implantations between 1988 and 2018 were determined. Trends in noninfectious complications within 30 days of implantation were analyzed. Results: A total of 157 (6.2%) of 2536 patients who received CIED experienced device complications. A total of 2.7% of the implants had major complications requiring intervention. Lead dislodgement was the most common (2.8%), followed by hematoma (1.7%). Complications went up from 1988 to 2005, and then showed a downtrend until 2018, driven by a decline in hematomas in the last decade ( Conclusion: Our study describes a real-world trend of CIED complications over 3 decades. Lead dislodgements and hematomas were the most common complications. Complications have declined over the last decade due to safer practices and a better understanding of anticoagulant management.

Indexed as

Cardiac resynchronization therapyCardiovascular implantable electronic devicesComplicationsImplantable cardioverter-defibrillatorPacemaker

Identifiers

PMID38560372
PMCPMC10980926
OpenAlexW4391817673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.